Bookmark
Forward
A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK Inhibitor.
Huibing Qiu, Qianwen Li, Yajie Xiao, Dongfang Wu, Rui Meng
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Apr
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Huibing Qiu, Qianwen Li, Yajie Xiao, Dongfang Wu, Rui Meng.
A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK Inhibitor.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2021 Apr;16(4):e21-e23
Mesh Tags
Adenocarcinoma of Lung
Carrier Proteins
DNA, Intergenic
Exons
Humans
Lung Neoplasms
Membrane Proteins
Oncogene Proteins, Fusion
Receptor Protein-Tyrosine Kinases
Substances
Carrier Proteins
DNA, Intergenic
LRRC1 protein, human
Membrane Proteins
Oncogene Proteins, Fusion
Receptor Protein-Tyrosine Kinases
PMID: 33781445
View Full Text